![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Sequent Scientific Limited Thane In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their significant offerings is Flunixin meglumine for veterinary use, Process-II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-371 - Rev 03
This Chemical Type CEP, issued on April 04, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1696 associated with this CEP further emphasizes